Skip to main content
. 2024 Feb;65(2):264–269. doi: 10.2967/jnumed.123.266211

TABLE 3.

Multivariate Analysis of Factors Associated with OS

Factor HR P Adjusted HR Adjusted P
PDA vs. SDA 0.51 (0.29–0.9) 0.018
Resection after SIRT, yes vs. no 0.17 (0.06–0.43) <10−3 0.15 (0.06–0.4) <10−3
Sex, female vs. male 0.86 (0.27–2.77) 0.797
Age, >65 y vs. ≤65 y 1.13 (0.63–2) 0.684
Child Pugh score, A6 or B7 vs. A5 1.61 (0.84–3.1) 0.151
ECOG, 1 vs. 0 1.23 (0.69–2.19) 0.471
Cirrhosis, yes vs. no 2.4 (0.94–6.12) 0.059
Multifocal vs. unifocal 20.3 (1.13–3.65) 0.016
Bilobar vs. unilobar 2.1 (1.17–3.76) 0.011 2.33 (1.24–4.37) 0.008
PVT, yes vs. no 1.88 (0.98–3.63) 0.054
Treatment line, subsequent vs. first 1.09 (0.54–2.21) 0.808
Index lesion size, ≥10 cm vs. <10 cm 0.99 (0.56–1.76) 0.968
AFP, ≥200 μg/L vs. <200 μg/L 1.6 (0.91–2.83) 0.098
Tumor involvement, ≥50% vs. <50% 0.95 (0.29–3.07) 0.927
TD, ≥205 Gy vs. <205 Gy 0.42 (0.22–0.81) 0.007
PLD, ≥150 Gy vs. <150 Gy 0.42 (0.23–0.75) 0.002

ECOG = Eastern Cooperative Oncology Group; AFP = α-fetoprotein.

Data in parentheses are 95% CIs.